Europe, 74 Years old, Male, Use ECCT as an Alternative Cancer Treatment for Stage 4 Prostate Cancer

Europe, Mr. Bruno, 74 Years old, Male, Paris

In September 2023, at the age of 72, he was diagnosed with prostate cancer of the adenocarcinoma type, with a high Gleason score of 9/10. A PET scan revealed that the cancer cells had infiltrated the entire prostate gland, with metastasis to the lymph nodes in the pelvic area and around the aorta, as well as spread to various points in the pelvic bones. His condition was already at stage 4 at the time of diagnosis.

There were not many treatment options available for a case with such widespread metastasis. He previously opted to take hormone-suppressing medication, undergo Impedence based Electric Cancer Therapy in Germany, and take GcMAF immunotherapy supplements from Japan. After about a year of treatment, follow-up PET scans showed that the cancer had continued to spread—lymph node metastasis had reached the entire chest and neck area, and bone metastasis had extended to the skull. Meanwhile, the tumor mass had completely filled the prostate.

While he is about to give up, he was introduced to ECCT as Alternative Cancer Treatment for Stage 4 Prostate Cancer by a colleague who had used it earlier. ECCT uses capacitive electric fields (non-contact, without current or shock), while the treatment he done in Germany uses impedance-based electric fields that are applied to the skin and involve electrical current. For ECCT, he was recommended to covered full-body device covering from head to toe, as the cancer had spread to lymph nodes and bones—indicating that cancer cells had already entered the bloodstream and lymphatic system throughout the body.

He initially strongly refused to wear the ECCT helmet that covered his face and neck. Hence, he began only using the ECCT blanket in December 2024. During treatment, he experienced no serious complications. As long as the areas of spread were adequately covered and the dead cells could be expelled properly, even widespread metastasis could still be resolved completely.

After just six months of using ECCT, a follow-up PET scan showed that the cancer masses had been largely cleared from the prostate and all previously affected areas—including the lymph nodes from the pelvic area up to the chest and all affected bones—except for the face and neck, which he had refused to put on the helmet from the beginning. Upon seeing the PET scan results, he finally accepted to also put on ECCT helmet to cover his face and neck.

So far, his condition has remained stable—almost indistinguishable from normal health. He continues to work and travels actively around the world for business along with ECCT.